How should headaches be evaluated and managed in a 64‑year‑old man with bipolar II disorder, post‑traumatic stress disorder, diabetes mellitus, chronic kidney disease, who is taking lamotrigine 50 mg daily?

Evaluation and Management of Headaches in This Patient

In this 64-year-old man with bipolar II disorder, PTSD, diabetes, and CKD taking lamotrigine 50 mg daily, first rule out secondary causes of headache (medication overuse, hypertension, cervical spine disease) through targeted history and examination, then treat as primary headache disorder with physical therapy or aerobic exercise as first-line, avoiding medications that worsen diabetes or kidney function. 1

Initial Evaluation: Red Flags and Secondary Causes

When evaluating headaches in patients over 50 years, specific warning signs require immediate attention 2:

• Age over 50 years itself is a red flag requiring careful evaluation for secondary causes 2
• Abrupt onset, neurologic signs, presence of cancer or immunosuppression, and provocation by physical activities or postural changes 2
• In this age group, secondary headaches are commonly caused by medication overuse, cervical spine disease, and hypertension 3

Critical assessment points specific to this patient:

• Medication overuse headache: Document exact frequency of analgesic use (both prescription and over-the-counter) as this is the leading secondary cause in patients over 50 3, 4
• Hypertension-related headache: Check blood pressure, as diabetes and CKD increase hypertension risk 3
• Cervical spine disease: Examine neck range of motion and palpate for cervical tenderness 3
• Depression screening: Use Beck Depression Inventory, as depression is significantly elevated in medication-overuse headache and correlates with headache disability 3
• Sleep apnea risk: Evaluate with STOP-BANG scale, particularly relevant given comorbid conditions 3

Comorbidity Considerations

The combination of bipolar II disorder and PTSD significantly complicates headache management:

• PTSD is comorbid with chronic migraine and chronic tension-type headache in up to 55% of cases 5, 6
• Patients with comorbid BD and PTSD experience worse symptoms and outcomes regardless of medication use 6
• This patient population shows higher use of benzodiazepines and antidepressants, which may contribute to medication overuse headache 6

Lamotrigine at 50 mg daily is a subtherapeutic dose for bipolar disorder (therapeutic range typically 100-400 mg), suggesting either recent initiation or inadequate treatment 7, 8. Lamotrigine itself is not commonly associated with headaches as a primary adverse effect 9.

Treatment Algorithm

First-Line: Non-Pharmacologic Interventions

Physical therapy or aerobic exercise should be the initial treatment approach for both tension-type headache and migraine in this patient 1:

• These interventions avoid medication interactions and metabolic complications
• Effective for both TTH and migraine prevention 1
• No contraindications given CKD or diabetes 1

Acute Treatment (If Primary Headache Confirmed)

For tension-type headache:

• Ibuprofen 400 mg or acetaminophen 1000 mg for acute episodes 1
• Caution: NSAIDs like ibuprofen should be used sparingly or avoided in CKD 1
• Acetaminophen is safer in CKD but monitor cumulative dose 1

For migraine:

• Acetaminophen, NSAIDs (with CKD precautions), or aspirin-acetaminophen-caffeine combinations 1
• Avoid triptans if cardiovascular disease is present (common with diabetes) 2
• Gepants (rimegepant, ubrogepant) are alternatives safe in cardiovascular disease, with nausea and dry mouth in 1-4% 2

Preventive Treatment Considerations

If preventive therapy becomes necessary, medication selection must account for multiple comorbidities:

Preferred options given this patient's profile:

• Lisinopril or angiotensin-receptor blockers: Beneficial for hypertension, diabetes, and CKD while preventing episodic migraine 1
• Magnesium: Safe in CKD (with monitoring), effective for migraine prevention 1

Options requiring caution:

• Topiramate: Effective for migraine prevention but can worsen cognitive function in elderly and has metabolic acidosis risk in CKD 1
• Valproate: Associated with increased diabetes risk (HRR 1.34) and should be avoided in this patient 10
• Amitriptyline: Effective for chronic TTH prevention but anticholinergic effects problematic in elderly; can worsen diabetes control 1
• Gabapentin: Not recommended for episodic migraine prevention 1

CGRP monoclonal antibodies (galcanezumab, fremanezumab, eptinezumab) or atogepant are effective for migraine prevention and have favorable safety profiles in diabetes and CKD, though cost may be prohibitive 1, 2.

Critical Pitfalls to Avoid

• Do not assume headaches are benign in a 64-year-old new presentation without thorough secondary cause evaluation 2, 3
• Do not add multiple CNS-active medications in a patient already on lamotrigine with PTSD—this increases fall risk and cognitive impairment 6
• Do not use valproate for headache prevention given diabetes risk 10
• Do not overlook medication overuse headache, which is associated with higher rates of hypothyroidism, GI problems, and depression in this age group 3
• Monitor kidney function closely if using any NSAIDs or magnesium 1

Integrated Psychiatric Care

Consider optimizing bipolar disorder treatment concurrently, as 50 mg lamotrigine is subtherapeutic 7, 8:

• Adequate lamotrigine dosing (typically 100-400 mg) may improve overall functioning and indirectly reduce headache burden 7
• Lamotrigine has no association with increased diabetes risk, unlike valproate and antipsychotics 10
• Comprehensive treatment addressing both PTSD and bipolar disorder simultaneously is necessary, as these conditions interact to worsen outcomes 5, 6